Search For "piramal pharma limited"
Piramal Critical Care and Blue-Zone Technologies collaborate to capture, c
Updated : 2 months, 3 weeks ago IST
Mumbai (Maharashtra) [India], February 6: Piramal Critical Care, Inc. (PCC), an overseas subsidiary of Piramal Pharma Limited, and Blue-Zone Technologies Ltd. (Blue-Zone) announced an agreement to collaborate on full lifecycle technology to capture and recycle waste anaesthetic gases.
Read More
Piramal Pharma to invest USD 90 million for infra expansion in US amid Tru
Updated : 1 year ago IST
Indian pharmaceutical major Piramal Pharma Limited has announced a USD 90 million investment plan towards expanding two of the Company's US facilities.
Read More
Cyril Amarchand Mangaldas advises on the debt availed by Piramal Critical
Updated : 3 years, 6 months ago IST
Mumbai (Maharashtra)/ New Delhi [India], November 11 (ANI/BusinessWire India): Cyril Amarchand Mangaldas advised State Bank of India, London Branch, Axis Bank Limited, IFSC Banking Unit (IBU) GIFT City Branch and HSBC, USA N.A., for debt aggregating up to USD 225 million, availed by Piramal
Read More
Piramal Pharma Consumer Products Division launches Wellify.in, an in-house
Updated : 3 years, 7 months ago IST
Mumbai (Maharashtra) [India] November 7 (ANI/ Piramal Pharma Limited (PPL): Piramal Pharma Limited Consumer Products Division (CPD), today announced the launch of its D2C platform, Wellify.in.
Read More
Piramal Pharma Ltd. to acquire 100% stake in Hemmo Pharmaceuticals, a lead
Updated : 5 years, 2 months ago IST
Mumbai (Maharashtra) [India], April 1 (ANI/PRNewswire): Piramal Pharma Limited's (PPL) Contract Development and Manufacturing Organization (CDMO), Piramal Pharma Solutions (PPS), announced today that PPL has entered into an agreement to acquire a 100 per cent stake in Hemmo Pharmaceuticals P
Read More
CCI gives nod to Carlyle Group's 20 per cent stake acquisition in Piramal
Updated : 5 years, 8 months ago IST
New Delhi [India], September 12 (ANI): The Competition Commission of India (CCI) has approved the proposed combination involving the acquisition of 20 per cent of the issued and paid-up equity share capital of Piramal Pharma Limited (Pharma Co) by CA Clover Intermediate II Investments (Curie
Read More